FOX BIZ NEWS: Regeneron COVID-19 drug trial halted in sickest patients


Regeneron COVID-19 drug trial halted in sickest patients



pended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with the most advanced disease.

Comments

Post a Comment

Popular posts from this blog